ARQIS advises BME on the acquisition of Mahler Group

13. April 2021

ARQIS has advised BME Group on the acquisition of the Mahler Group – a leading general building materials and tiles distributor in Bavaria. The sale of shares is still subject to approval by the relevant competition authorities and is expected to be completed in the course of 2021.

BME is one of Europe’s leading building material distribution companies and active in the distribution of building materials in Germany under the brands Bauking (General Builders Merchant) as well as Paulsen Gruppe, Detering, Bergmann & Franz (all Sanitary, Heating & Plumbing merchants). With the acquisition of the Mahler Group, Bauking will expand its footprint to the South of Germany.

The Mahler Group operates under the brands Bauwaren Mahler, Mahler Bayerische Bauwaren, Mahler Fliesen & Glasbau, and Hillari Fliesencenter. The Group has a network of five branches and employs a total of 273 employees.

The ARQIS focus group Transactions around Dr. Jörn-Christian Schulze has advised BME once again. During the acquisition of Detering in summer 2020 the team worked for the then newly formed BME Group for the first time. Previously, ARQIS had accompanied the acquisitions of the Paulsen Group and Bergmann & Franz Group on behalf of the former parent company CRH plc.

Advisors to BME

ARQIS (Dusseldorf): Dr. Jörn-Christian Schulze (Lead; Corporate/M&A), Dr. Ulrich Lienhard (Real Estate), Marcus Nothhelfer (Commercial & IP/IT; Munich), Tobias Neufeld (Pensions & Data Protection); Counsel: Thomas Chwalek (Corporate/M&A), Sina Janke (Compliance); Associates: Kamil Flak, Dr. Nima Hanifi-Atashgah (both Corporate/M&A), Jennifer Huschauer (Real Estate), Nora Meyer-Stratmann, Rolf Tichy (both Commercial & IP/IT), Martin Weingärtner (Pensions & Labour Law), Eva Kraszkiewicz, Juliane Lewen (both Data Protection), Waldemar Rembold (Risk); Legal Specialist: Gloria Bittner-Schützendorf (Commercial)

Niitväli (Frankfurt): Evelyn Niitväli (Antitrust)


If you have any questions, please write to us.